Objective: We aimed to determine whether optical coherence tomography (OCT) findings could differentiate DIP from Parkinson’s disease (PD).

Background: Drug-induced parkinsonism (DIP) is common, but diagnosis is challenging. Although dopamine transporter (DAT) imaging is useful, the cost and inconvenience are problematic, and an easily accessible screening technique is needed.

Method: We investigated 97 de novo PD patients and 27 DIP patients using OCT and [¹⁸F] N-(3-fluoropropyl)-2b-carbon ethoxy-3b-(4-iodophenyl) nortropane (FP CIT) positron emission tomography (PET). We compared peripapillary retinal nerve fiber layer thickness (pRNFLT) and macular retinal thickness (mRT) between PD and DIP patients as well as interocular differences in the pRNFLT and the mRT. Asymmetric index (%) for retinal thickness (AIRT) was calculated to measure the interocular differences between pRNFLT and mRT. The correlation between AIRT and total striatal specific/non-specific binding ratio asymmetry index (SNBRAI) was investigated in PD and DIP patients.

Results: No significant differences in pRNFLT and mRT values were observed between PD and DIP patients (all p-values > 0.09). The mean SNBRAI was significantly higher in PD than in DIP (p = 0.007) patients; however, AIRT did not differ between PD and DIP patients in pRNFLT and mRT (all p-values > 0.10). SNBRAI did not correlate with AIRT of pRNFL or mRT in PD and DIP patients (all p-values > 0.06).

Conclusion: Our study showed no benefit of retinal thickness and interocular asymmetry measurements using OCT for distinguishing PD from DIP in the early stages. Additional investigations are needed for confirmation.

« Back to 2023 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/can-optical-coherence-tomography-differentiate-parkinsons-disease-from-drug-induced-parkinsonism/